| |
| |
|
| Insider
Information: |
Higgons John Duncan |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
130,547 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,724,042 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
130,547 |
|
|
| Total
Value |
$5,724,042 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agios Pharmaceuticals Inc |
AGIO |
Chief Operating Officer |
2016-01-04 |
120,834 |
|
0 |
Premium* |
|
|
Jounce Therapeutics Inc |
JNCE |
Director |
2021-04-15 |
9,713 |
2017-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
66 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JNCE |
Jounce Therapeutics Inc |
Director |
– • – |
2021-04-15 |
4 |
AS |
$10.00 |
$2,000 |
D/D |
(200) |
9,713 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Director |
– • – |
2021-03-15 |
4 |
AS |
$12.80 |
$2,560 |
D/D |
(200) |
9,913 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Director |
– • – |
2021-02-16 |
4 |
AS |
$11.78 |
$2,356 |
D/D |
(200) |
10,113 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Director |
– • – |
2021-01-21 |
4 |
AS |
$11.11 |
$2,222 |
D/D |
(200) |
10,313 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Director |
– • – |
2021-01-20 |
4 |
AS |
$12.00 |
$18,000 |
D/D |
(1,500) |
10,513 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Director |
– • – |
2020-01-06 |
4 |
AS |
$8.11 |
$12,165 |
D/D |
(1,500) |
12,013 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Director |
– • – |
2017-02-01 |
4 |
B |
$16.00 |
$107,200 |
D/D |
6,700 |
27,025 |
2.39 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2015-12-15 |
4 |
AS |
$50.09 |
$1,001,800 |
D/D |
(20,000) |
61,835 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2015-10-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
70,000 |
81,835 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2015-10-15 |
4 |
AS |
$71.04 |
$1,420,800 |
D/D |
(20,000) |
81,835 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2015-11-16 |
4 |
AS |
$61.51 |
$1,230,200 |
D/D |
(20,000) |
81,835 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2015-05-15 |
4 |
AS |
$112.89 |
$837,305 |
D/D |
(7,417) |
98,835 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2015-10-15 |
4 |
OE |
$0.30 |
$6,244 |
D/D |
20,000 |
101,835 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2015-11-16 |
4 |
OE |
$0.47 |
$21,764 |
D/D |
20,000 |
101,835 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2015-04-15 |
4 |
AS |
$99.54 |
$655,272 |
D/D |
(6,583) |
106,252 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2015-06-10 |
4 |
OE |
$0.30 |
$3,025 |
D/D |
10,000 |
108,835 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating OfficerOfficer |
• – • |
2013-07-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
109,090 |
|
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2014-01-21 |
4 |
AS |
$34.71 |
$416,530 |
D/D |
(12,000) |
109,090 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2014-02-03 |
4 |
AS |
$25.97 |
$207,728 |
D/D |
(8,000) |
109,090 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2014-02-18 |
4 |
AS |
$35.06 |
$82,531 |
D/D |
(2,354) |
109,090 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2014-03-03 |
4 |
AS |
$29.85 |
$238,832 |
D/D |
(8,000) |
109,090 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2014-03-06 |
4 |
AS |
$35.54 |
$200,659 |
D/D |
(5,646) |
109,090 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2014-03-07 |
4 |
AS |
$45.10 |
$405,900 |
D/D |
(9,000) |
109,090 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2014-02-18 |
4 |
OE |
$0.30 |
$712 |
D/D |
2,354 |
111,444 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2015-03-16 |
4 |
AS |
$106.24 |
$743,680 |
D/D |
(7,000) |
112,835 |
0 |
- |
|
66 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
